eXoZymes, Inc. (EXOZ) Stock Analysis & Investment Frameworks
eXoZymes, Inc. (EXOZ) stock analysis on Invetso. Review eXoZymes, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
eXoZymes, Inc. Company Overview
- Exchange: NASDAQ Global Market
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
eXoZymes, Inc. Key Financial Metrics
- Market Cap: $37.13M
- Revenue: $N/A
- ROE: -292.13%
- ROIC: -155.79%
- Dividend Yield: N/A
About eXoZymes, Inc.
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
eXoZymes, Inc. Investment Frameworks
Invetso analyzes eXoZymes, Inc. (EXOZ) across the following frameworks:
- eXoZymes, Inc. 10Y Growth Potential
- eXoZymes, Inc. Scenario Analysis
- eXoZymes, Inc. Risks & Opportunities
- eXoZymes, Inc. Economic Moat
- eXoZymes, Inc. Business Model
- eXoZymes, Inc. Management
- eXoZymes, Inc. SWOT Analysis
- eXoZymes, Inc. Porter's 5 Forces
- eXoZymes, Inc. PESTLE Analysis
- eXoZymes, Inc. ESG Analysis